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Background
Soluble guanylate cyclase (sGC) is the main receptor of
nitric oxide (NO). NO binds to the ferrous heme moiety
of sGC thus activating the enzyme and increasing cyclic
GMP (cGMP) levels. sGC is inhibited by various oxidants
which either convert ferrous heme to ferric suppressing
NO binding or modify essential thiol groups of sGC. Cer-
tain heat shock proteins (Hsp) can protect the enzymes
from this inactivation. Hence, we suggested that Hsp can
block oxidant-induced inhibition of sGC.
Results
In the present study purified sGC (human and bovine)
and Hsps (human and rabbit) were used. According to
surface plasmon resonance binding experiments, Hsp90
can directly interact with sGC. Formation of the Hsp90-
sGC complex was not inhibited by a known Hsp90 inhib-
itor geldanamycin. The data indicate that association is
slow (ka = 1.08·104 M-1 s-1) and dissociation is also very
slow (kd = 2.48·10-4 s-1). The resulting KD value of 23.1
nM suggests that the binding is characterized by high
affinity. Cyclic GMP accumulation was measured in the
presence of an NO donor. Preincubation of sGC at 37 C
significantly (by 90–95%) inhibited enzyme activity. If
Hsp90 (0.1 mg/ml) was present during preincubation,
inhibition of sGC was completely abolished. However,
other Hsps (70, 60, 40 and 25) failed to protect sGC.
Hsp90 protected sGC from inhibition by various transi-
tion metal ions including Mn2+ and Cd2+ known to be
potent blockers of thiol groups. On the other hand,
Hsp90 had no effect on inhibition of sGC by 1H-
[1,2,4]oxadiazole[4,3-a]quinoxalin-1-one. Thus, Hsp90
protects essential thiols of sGC (but not the heme iron)
from oxidative modification.
Conclusion
The complex of Hsp90 and sGC is formed slowly but once
formed, should remain relatively stable for a long period
of time. Hsp90 protects essential functional groups of the
enzyme but does not stimulate the enzyme activity. The
interaction of Hsp90 with sGC can be important for main-
tenance of NO-dependent cellular cGMP synthesis in
damaged tissues.
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